We are looking for a talented and ambitious individual to participate in the research group of Prof. Dr. VP Retèl. In our group, we are working on a broad scala of projects regarding (very) early Health Technology Assessment (HTA) of innovative technologies in precision oncology. The projects are research-based as well as policy/clinic-based, due to the nature of the NKI-AVL, which is a research institute and hospital in one. Our group includes 10 PhD students, 3 postdocs and 1 research assistant.
For the hospital, the program manager-part is expected to have a coordinating role in the development of a real-time data & research pipeline for projects concerning the Center of Early Detection (AVL Centrum voor Vroegdiagnostiek: Kanker vroeg ontdekken). This data pipeline will function as a framework for continuous HTA analyses throughout the patient trajectory, from early detection until palliative care, for both research purposes as well as policy decision making purposes. Besides, other projects are possible, such as preparing HTA dossiers for technologies developed at the NKI for submission to the national HTA-body (Zorginstituut).
For the research institute, the senior research-part will have a role in the HTA research facility, collaborating with the other postdocs. Consultations from the clinic as well as the research institute will be coordinated, such as preparing grant proposals (incorporating HTA), supporting and performing HTA analyses. Analysis can entail a broad scala of HTA/health economics research; mostly (early) cost-effectiveness analyses, but also budget impact analyses, Quality-of-life analysis, patient preference research, resource use analysis etc. We work on continuous HTA-models alongside the real-world data-infrastructure from the data lakehouse, including combining clinical, PROMs and financial data. Furthermore, a supervisory role is possible for PhD and master students, to support them in their research.
We are looking for an individual who sees this as career challenge, and is interested in discussing the design and results of broader HTA projects with physicians and other healthcare professionals in the Antoni van Leeuwenhoek hospital. This close collaboration between research and clinical practice supports new innovations to be implemented most optimally and as fast as possible into the clinic. We are curious to hear from you the opportunities you see in this environment, with a preference for data science expertise (or affinity to learn), seen the topics described.
Supervisors for projects are Prof. Dr. Valesca Retèl and Prof. Dr. Wim van Harten, in collaboration with the various project specific principal investigators such as fundamental researchers and clinicians at the Antoni van Leeuwenhoek hospital. We have many interesting research lines in e.g. RWD, pricing & transparency, personalized medicine, cell therapy, immunotherapy, cancer rehabilitation, de-escalation etc.
Inspiring international atmosphere
Approximately 550 people work in the NKI research laboratory and many of the clinicians are involved in research. Work discussions, lectures and seminars are inspiring and a large number of non-Dutch post-docs, students and staff members contribute to the stimulating and international atmosphere of the Institute.
We are searching for a research investigator/program manager with the following expertise and experience:
-
You have a PhD degree in Health Economics, Data Science, Health Sciences, Epidemiology, or any related field, with experience in aspects related to HTA/ health economics and data science in healthcare, motivated to work in the hospital setting;
-
You have affinity with data science, (AI) skills, to be developed further;
-
Experience with performing statistical analyses/modelling (e.g. R, Stata, Excel or Python);
-
You have good verbal and written communication skills (Dutch/English);
-
Interest in Health care policy.
The basis for your employment conditions is in accordance with the CLA Hospitals. You will receive from us:
-
A year's contract for 36 hours per week, with the possibility of extension;
-
A gross monthly salary between € 3.826,- and € 7.127,-, based on a 36-hour working week, in line with FWG55, 60 or 65 and depending on your experience;
-
144 holiday hours and 57 hours of Personal Life Budget, with full-time employment;
-
Annual holiday pay of 8.33% and a fixed end-of-year bonus of 8.33%;
-
A travel allowance of €0.23 per km;
-
Free parking at the Netherlands Cancer Institute. And with our bicycle plan and discount on public transport we also make it attractive for you to leave the car at home;
-
Opportunity to exercise at our Fit Boutiqs;
-
An active staff association.
We are curious about your talent! Will you be the one to make a difference in the world of cancer care and research? Apply now by using the application/solliciteer button. Please submit your CV, names and contact information of referents, and a cover letter describing education, research experience, interests and vision for this position to the application form. You can only upload two files so make sure to include your reference information together with your CV or cover letter. Please note: applications by email cannot be processed.
The closing date is June 21, 2026. The first (online) round of job interviews will be scheduled in the week of June 29, the second (face to face) round in the week of July 13.
For further information and addresses visit our home page or contact prof. V.P. Retèl ([email protected]).
The Netherlands Cancer Institute (NKI) is an independent research institute located in Amsterdam. The Institute covers all major areas of molecular and cellular cancer biology, with special emphasis on immunology, cancer cell biology and translational research; increasingly health technology assessment (HTA) and health economic studies are performed in early stages of research that can lead to clinical innovations. The Netherlands Cancer Institute and the Antoni van Leeuwenhoek Hospital form an comprehensive cancer center, combining a research laboratory and a hospital under one roof in a single, independent organization This research is focused on improving cancer treatment through imaging and molecular diagnostics, new medicine, immunotherapy, improved operating techniques, more effective radiotherapy, and combinations of these, HTA, epidemiology and psychosocial research.
